The effects of all-trans retinoic acid on proliferation and differentiation in ovarian cancer cell line COC1
Min Yang
Abstract
Min Yang
Abstract
Objective:To investigate the effects of all-trans retinoic acid (ATRA) on prolifetation and differentiation in ovarian cancer cell line COC1 in vitro.Methods:Human ovarian cancer cell line COC1 was cultured in medium containing ATRA in different concentrations in vitro.Cell proliferation inhibition was tested by MTT assay.The cell cycle was analyzed by flow cytometry(FCM).Morphological changes of cell differentiation were observed by light and transmission electron microscopy,and the expression of Ki-67 in cancer cells were measured with SP immunohistochemistry.In addition,CA 125 expression in the culture medium was measured by ELISA.Results:ATRA of 10 -7 ~10 -5 mol/L inhibited COC1 cell proliferation significantly in a dose-dependent and time-dependent manner.With the increase of ATRA concentrations,the number of cells in G 0/G 1 phase were elevated,the number of cells in S phase were obviously decreased.COC1 cells after treated by ATRA showed striking morphological characteristics of differentiation.The expression of Ki-67 was decreased in COC1 after ATRA treatment.ATRA could also suppress the expression of CA125 tumor marker in COC1 cells.Conclusion:ATRA can both inhibit proliferation and induce differentiation of human ovarian cancer cell line COC1.These results may provide an effective and novel approach for clinical treatment of human ovarian cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of all-trans retinoic acid (ATRA) on prolifetation and differentiation in ovarian cancer cell line COC1 in vitro.Methods:Human ovarian cancer cell line COC1 was cultured in medium containing ATRA in different concentrations in vitro.Cell proliferation inhibition was tested by MTT assay.The cell cycle was analyzed by flow cytometry(FCM).Morphological changes of cell differentiation were observed by light and transmission electron microscopy,and the expression of Ki-67 in cancer cells were measured with SP immunohistochemistry.In addition,CA 125 expression in the culture medium was measured by ELISA.Results:ATRA of 10 -7 ~10 -5 mol/L inhibited COC1 cell proliferation significantly in a dose-dependent and time-dependent manner.With the increase of ATRA concentrations,the number of cells in G 0/G 1 phase were elevated,the number of cells in S phase were obviously decreased.COC1 cells after treated by ATRA showed striking morphological characteristics of differentiation.The expression of Ki-67 was decreased in COC1 after ATRA treatment.ATRA could also suppress the expression of CA125 tumor marker in COC1 cells.Conclusion:ATRA can both inhibit proliferation and induce differentiation of human ovarian cancer cell line COC1.These results may provide an effective and novel approach for clinical treatment of human ovarian cancer.
Key concepts: Retinoic acid, Ovarian cancer, Cell culture, Cell growth, Flow cytometry, Cell cycle, MTT assay, Cell